CA2157376C - Compositions de vaccin contenant du derive 3-o-desacetyle du lipide a monophosphoryle - Google Patents

Compositions de vaccin contenant du derive 3-o-desacetyle du lipide a monophosphoryle Download PDF

Info

Publication number
CA2157376C
CA2157376C CA002157376A CA2157376A CA2157376C CA 2157376 C CA2157376 C CA 2157376C CA 002157376 A CA002157376 A CA 002157376A CA 2157376 A CA2157376 A CA 2157376A CA 2157376 C CA2157376 C CA 2157376C
Authority
CA
Canada
Prior art keywords
mpl
vaccine composition
antigen
vaccine
hbsag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002157376A
Other languages
English (en)
Other versions
CA2157376A1 (fr
Inventor
Pierre Hauser
Pierre Voet
Moncef Slaoui
Nathalie Marie-Josephe Garcon-Johnson
Pierre Desmons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939306029A external-priority patent/GB9306029D0/en
Priority claimed from GB9403417A external-priority patent/GB9403417D0/en
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to CA002555911A priority Critical patent/CA2555911C/fr
Priority claimed from PCT/EP1994/000818 external-priority patent/WO1994021292A1/fr
Publication of CA2157376A1 publication Critical patent/CA2157376A1/fr
Application granted granted Critical
Publication of CA2157376C publication Critical patent/CA2157376C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CA002157376A 1993-03-23 1994-03-14 Compositions de vaccin contenant du derive 3-o-desacetyle du lipide a monophosphoryle Expired - Lifetime CA2157376C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002555911A CA2555911C (fr) 1993-03-23 1994-03-14 Compositions d'adjuvant contenant le lipide a monophosphoryle 3-o-deacetyle

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB939306029A GB9306029D0 (en) 1993-03-23 1993-03-23 Vaccine compositions
GB9306029.1 1993-03-23
GB9403417.0 1994-02-23
GB9403417A GB9403417D0 (en) 1994-02-23 1994-02-23 Vaccine compositions
PCT/EP1994/000818 WO1994021292A1 (fr) 1993-03-23 1994-03-14 Compositions vaccinales renfermant le lipide a monophosphorylique 3-o desacetyle

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002555911A Division CA2555911C (fr) 1993-03-23 1994-03-14 Compositions d'adjuvant contenant le lipide a monophosphoryle 3-o-deacetyle

Publications (2)

Publication Number Publication Date
CA2157376A1 CA2157376A1 (fr) 1994-09-29
CA2157376C true CA2157376C (fr) 2006-10-31

Family

ID=37394902

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002157376A Expired - Lifetime CA2157376C (fr) 1993-03-23 1994-03-14 Compositions de vaccin contenant du derive 3-o-desacetyle du lipide a monophosphoryle

Country Status (1)

Country Link
CA (1) CA2157376C (fr)

Also Published As

Publication number Publication date
CA2157376A1 (fr) 1994-09-29

Similar Documents

Publication Publication Date Title
EP0812593B1 (fr) Compositions vaccinales renfermant de lipide A monophosphorylique 3-0-desacétylé
CA2132833C (fr) Vaccins contre l'hepatite renfermant du monophosphoryl-lipide a desacyle 3-o
JP3881015B2 (ja) Ｂ型肝炎ワクチン
US6893644B2 (en) Hepatitis vaccines containing 3-O-deacylated monophoshoryl lipid A
CA2157376C (fr) Compositions de vaccin contenant du derive 3-o-desacetyle du lipide a monophosphoryle
AU705739B2 (en) A method of preparing vaccine compositions containing 3-0-deacylated monophosphoryl lipid A
CA2555911C (fr) Compositions d'adjuvant contenant le lipide a monophosphoryle 3-o-deacetyle
US20020192224A1 (en) Hepatitis b vaccine

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140314